Lisa Parker, a philosopher, is the Dickie, McCamey & Chilcote Professor of Bioethics, Director of the Center for Bioethics & Health Law, and Professor of Human Genetics in the School of Public Health. She directs the University’s interdisciplinary Master of Arts in Bioethics Program in The Dietrich School of Arts and Sciences, and is director of the Area of Concentration in Humanities, Ethics, and Palliative Care in the School of Medicine. She is also a member of the Steering Committee of the Gender, Sexuality, and Women's Studies Program and a fellow of the Center for Philosophy of Science. She leads the University’s Research, Ethics, and Society Initiative, designed to foster campus-wide discussion of research ethics and the social implications of scientific research and technology.
Dr. Parker has published extensively on ethical concerns related to the design and conduct of research, particularly genetic research and mental health research, as well as on aesthetic surgery, confidentiality, and informed consent. Her recent research has focused on the ethical management of incidental findings and return of research results, privacy protection, pharmacogenomic research and genetic enhancement. She has a sustained interest in employing feminist approaches to bioethical issues and in the critical analysis of bioethics as a social practice and field of inquiry. She served as a co-investigator for international research ethics training programs focused in China, Egypt, and India. She has chaired the Genomics and Society Working Group of the National Advisory Council for Human Genome Research for the NHGRI, where she has served on the study section of the ELSI Program (the Ethical, Legal, and Social Implications Program) and on national working groups examining the management of incidental findings and research results. She also serves on the Expert Scientific Panel of the Electronic Medical Records and Genomics (eMERGE) Network and on the NHGRI Advisory Council.
Dr. Parker collaborates with investigators across the University, as well as nationally and internationally, on both empirical studies and theoretical and policy analyses. Topics of her research collaborations range from depression treatment to traumatic brain injury and mild cognitive impairment. She currently serves as an ethics consultant on studies involving biobanking and whole exome/genome sequencing in different patient populations, and is a faculty member in the University’s Institute for Precision Medicine.